Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country's current outbreak
As China relaxes pandemic restrictions and reopens to foreign travelers, clinics and hospital hallways overflow with patients amid a wave of infections that is testing the healthcare system, following the abrupt removal of the so-called zero-Covid strategy. Photo: Noel Celis/AFP/Getty ImagesChinese drugmaker CanSino Biologics Inc.
The Tianjin-based biotech firm plans to produce 100 million doses of the vaccine, designed to combat Omicron, during the first phase of manufacturing, according to a company release posted to its social-media account late on Thursday.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Chinese-made mRNA vaccine starts trial productionChina's CanSino Biologics Inc has entered 'test production phase' for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday.
Leer más »
Chinese traveler arrested after fleeing covid isolation, Korean police sayThe arrest ended a two-day manhunt in South Korea, where almost one-third of short-term visitors from China recently tested positive for coronavirus.
Leer más »
South Korea police find Chinese man missing after being sent to COVID quarantineSouth Korean police found on Thursday a Chinese man who went missing after testing positive for COVID-19 upon arrival, and said he would be taken to a quarantine facility and could later be charged under a disease control law.
Leer más »
COVID infected Chinese tourist caught in South Korea after fleeing quarantine centerA Chinese man was able to evade South Korean authorities for two days after fleeing mandatory quarantine when he tested positive for COVID-19 upon arrival in the country.
Leer más »
Chinese health authority adjusts COVID prevention and control measuresChina's main health authority on Friday adjusted COVID-19 prevention and control measures, saying it aimed to optimise clinical categorisation and treatment nearly a month after it scrapped a rigid zero-COVID policy.
Leer más »